File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Metabolomics strategy comprehensively unveils the effect of catechins intervention on the biomarkers of exposure to acrylamide and biomarkers of cardiometabolic risk

TitleMetabolomics strategy comprehensively unveils the effect of catechins intervention on the biomarkers of exposure to acrylamide and biomarkers of cardiometabolic risk
Authors
KeywordsAcrylamide
Cardiometabolic risk
Catechins
Metabolomics
Phenylalanine metabolism
Issue Date2022
Citation
Environment International, 2022, v. 169, article no. 107517 How to Cite?
AbstractPolyphenolic antioxidants have been suggested to control the generation of acrylamide during thermal reactions. However, their role in protecting against the toxicity of acrylamide and the mechanism of action regarding profile alteration of biomarkers and metabolome remains unclear. A total of 65 adults were randomized into tea polyphenols (TP) and control groups and served with potato chips, which corresponded to an intake level of 12.6 μg/kg·bw of acrylamide, followed by capsules containing 200 mg, 100 mg or 50 mg TP, or equivalent placebo. Moreover, nontargeted urinary metabolomics analysis in acrylamide exposed rats was conducted using ultra-high performance liquid chromatography linked with a quadrupole-orbitrap high-resolution mass spectrometry. Our results showed that supplementation with catechins promoted the excretion of N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine in both humans and rats. We also found that epigallocatechin gallate (EGCG) or epicatechin (EC) intervention attenuated the ratio of hemoglobin adduct of glycidamide to hemoglobin adduct of acrylamide in rat blood. Metabolomics analysis revealed that EGCG/EC intervention regulated the differential expressed metabolites, including L-glutamic acid, 2-oxoglutarate, citric acid, and cysteinylglycine. Kyoto Encyclopedia of Genes and Genomes pathway analysis further showed acrylamide-induced metabolic disorders were improved after EGCG/EC supplementation by glycolipid metabolism (alanine, aspartate and glutamate metabolism, and D-Glutamine and D-glutamate metabolism) and energy metabolism (tricarboxylic acid cycle). Notably, the supplement use of EGCG prevented the cardiometabolic risk after exposure to acrylamide by mediating the phenylalanine and hippuric acid in phenylalanine metabolism. Here we showed the beneficial effect of catechins as major polyphenolic antioxidant ingredients on the toxicity of acrylamide by the changes in biomarkers from metabolic profile analysis based on human and animal studies. These findings shed light into the catechins as natural polyphenolic antioxidants that could be a therapeutic ingredient for preventing acrylamide-induced cardiometabolic toxicity.
Persistent Identifierhttp://hdl.handle.net/10722/342755
ISSN
2023 Impact Factor: 10.3
2023 SCImago Journal Rankings: 3.015
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWan, Xuzhi-
dc.contributor.authorJia, Wei-
dc.contributor.authorWang, Qiao-
dc.contributor.authorChen, Xinyu-
dc.contributor.authorWang, Anli-
dc.contributor.authorZhu, Li-
dc.contributor.authorLiu, Xiaohui-
dc.contributor.authorZhang, Lange-
dc.contributor.authorZhuang, Pan-
dc.contributor.authorJiao, Jingjing-
dc.contributor.authorZhang, Yu-
dc.date.accessioned2024-04-17T07:06:01Z-
dc.date.available2024-04-17T07:06:01Z-
dc.date.issued2022-
dc.identifier.citationEnvironment International, 2022, v. 169, article no. 107517-
dc.identifier.issn0160-4120-
dc.identifier.urihttp://hdl.handle.net/10722/342755-
dc.description.abstractPolyphenolic antioxidants have been suggested to control the generation of acrylamide during thermal reactions. However, their role in protecting against the toxicity of acrylamide and the mechanism of action regarding profile alteration of biomarkers and metabolome remains unclear. A total of 65 adults were randomized into tea polyphenols (TP) and control groups and served with potato chips, which corresponded to an intake level of 12.6 μg/kg·bw of acrylamide, followed by capsules containing 200 mg, 100 mg or 50 mg TP, or equivalent placebo. Moreover, nontargeted urinary metabolomics analysis in acrylamide exposed rats was conducted using ultra-high performance liquid chromatography linked with a quadrupole-orbitrap high-resolution mass spectrometry. Our results showed that supplementation with catechins promoted the excretion of N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine in both humans and rats. We also found that epigallocatechin gallate (EGCG) or epicatechin (EC) intervention attenuated the ratio of hemoglobin adduct of glycidamide to hemoglobin adduct of acrylamide in rat blood. Metabolomics analysis revealed that EGCG/EC intervention regulated the differential expressed metabolites, including L-glutamic acid, 2-oxoglutarate, citric acid, and cysteinylglycine. Kyoto Encyclopedia of Genes and Genomes pathway analysis further showed acrylamide-induced metabolic disorders were improved after EGCG/EC supplementation by glycolipid metabolism (alanine, aspartate and glutamate metabolism, and D-Glutamine and D-glutamate metabolism) and energy metabolism (tricarboxylic acid cycle). Notably, the supplement use of EGCG prevented the cardiometabolic risk after exposure to acrylamide by mediating the phenylalanine and hippuric acid in phenylalanine metabolism. Here we showed the beneficial effect of catechins as major polyphenolic antioxidant ingredients on the toxicity of acrylamide by the changes in biomarkers from metabolic profile analysis based on human and animal studies. These findings shed light into the catechins as natural polyphenolic antioxidants that could be a therapeutic ingredient for preventing acrylamide-induced cardiometabolic toxicity.-
dc.languageeng-
dc.relation.ispartofEnvironment International-
dc.subjectAcrylamide-
dc.subjectCardiometabolic risk-
dc.subjectCatechins-
dc.subjectMetabolomics-
dc.subjectPhenylalanine metabolism-
dc.titleMetabolomics strategy comprehensively unveils the effect of catechins intervention on the biomarkers of exposure to acrylamide and biomarkers of cardiometabolic risk-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.envint.2022.107517-
dc.identifier.pmid36191485-
dc.identifier.scopuseid_2-s2.0-85139059602-
dc.identifier.volume169-
dc.identifier.spagearticle no. 107517-
dc.identifier.epagearticle no. 107517-
dc.identifier.eissn1873-6750-
dc.identifier.isiWOS:000869108700011-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats